Skip to main content

Advertisement

Table 1 Summary of clinical course

From: Imipenem/cilastatin sodium (IPM/CS) as an embolic agent for transcatheter arterial embolisation: a preliminary clinical study of gastrointestinal bleeding from neoplasms

Pt. no Age Sex Disease Outcome Proc no. Extravasation Embolized artery IPM/CS (g) Rebleeding (day)
1 53 M Pancreatic cancer Died at day 247 1 + PA 0.5 -
2 59 M Malignat lymphoma Died at day 163 2 + JA 2.2 0
    3   JA 0.6 -
3 68 M Pancreatic lymphoma Died at day 48 4   IA 0.5 21
    5   IA 1.0 1
4 73 M Pancreatic cancer Transferred at day 44 6   PA 1.5 10
    7   PA 1.4 -
5 64 M Metastasis to the pancreas Died at day 224 8   PA 0.9 -
6 46 F Invasion of cervical cancer to the rectum Transferred at day 339 9 10   IRA 0.4 0
        SRA 0.4 -
7 43 F Colon cancer Died at day 37 11 + LCA   -
  1. Pt. no., patient number; Proc. no., procedure number; PA, pancreatic arcade; JA, jejunal artery; IA, ileal artery; RCC, renal cell carcinoma; IRA, inferior rectum artery; SRA, superior rectum artery; LCA; left colic artery.